309 related articles for article (PubMed ID: 12701967)
1. Immunopathological study of mesonephric lesions of cervix uteri and vagina.
Kondi-Pafitis A; Kairi E; Kontogianni KI; Dimopoulou C; Sikiotis K; Smyrniotis V
Eur J Gynaecol Oncol; 2003; 24(2):154-6. PubMed ID: 12701967
[TBL] [Abstract][Full Text] [Related]
2. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
3. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
4. Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases.
Ferry JA; Scully RE
Am J Surg Pathol; 1990 Dec; 14(12):1100-11. PubMed ID: 2252101
[TBL] [Abstract][Full Text] [Related]
5. The histogenetic origin of cervical mesonephric hyperplasia and mesonephric adenocarcinoma of the uterine cervix studied with immunohistochemical methods.
Lang G; Dallenbach-Hellweg G
Int J Gynecol Pathol; 1990; 9(2):145-57. PubMed ID: 1692008
[TBL] [Abstract][Full Text] [Related]
6. Florid mesonephric hyperplasia of the cervix: a report of a case with review of the literature.
Ayroud Y; Gelfand MM; Ferenczy A
Int J Gynecol Pathol; 1985; 4(3):245-54. PubMed ID: 2414240
[TBL] [Abstract][Full Text] [Related]
7. [Mesonephric hyperplasia in uterine cervix: report of two cases].
Zeng Y; Wu Y; Zhu X; Zhang S; Gu P; Zhu H; Qiu W; Yi X
Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):339-40. PubMed ID: 25030871
[No Abstract] [Full Text] [Related]
8. Mesonephric hyperplasia of the uterine cervix: a clinicopathologic study of 51 cases.
Seidman JD; Tavassoli FA
Int J Gynecol Pathol; 1995 Oct; 14(4):293-9. PubMed ID: 8598330
[TBL] [Abstract][Full Text] [Related]
9. Mesonephric remnants or hyperplasia can cause abnormal pap smears: a study of three cases.
Welsh T; Fu YS; Chan J; Brundage HA; Rutgers JL
Int J Gynecol Pathol; 2003 Apr; 22(2):121-6. PubMed ID: 12649665
[TBL] [Abstract][Full Text] [Related]
10. Urethral obstruction due to lobular mesonephric hyperplasia of the vagina--a case report.
Handoo A; Kini H; Pai R; Prabhu GG
Indian J Pathol Microbiol; 2005 Jan; 48(1):20-1. PubMed ID: 16758778
[TBL] [Abstract][Full Text] [Related]
11. Mesonephric adenocarcinoma (endometrioid type) of endocervix with diffuse mesonephric hyperplasia involving cervical wall and myometrium: an unusual case report.
Menon S; Kathuria K; Deodhar K; Kerkar R
Indian J Pathol Microbiol; 2013; 56(1):51-3. PubMed ID: 23924560
[TBL] [Abstract][Full Text] [Related]
12. Differential Expression Patterns of GATA3 in Uterine Mesonephric and Nonmesonephric Lesions.
Roma AA; Goyal A; Yang B
Int J Gynecol Pathol; 2015 Sep; 34(5):480-6. PubMed ID: 25851711
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
Cina SJ; Richardson MS; Austin RM; Kurman RJ
Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
[TBL] [Abstract][Full Text] [Related]
14. Clear cell carcinoma of the uterine endocervix with an in situ component.
Hasumi K; Ehrmann RL
Cancer; 1978 Nov; 42(5):2435-8. PubMed ID: 719620
[TBL] [Abstract][Full Text] [Related]
15. Mesonephric remnant hyperplasia of the cervix: a clinicopathologic analysis of 14 cases.
Jones MA; Andrews J; Tarraza HM
Gynecol Oncol; 1993 Apr; 49(1):41-7. PubMed ID: 8482559
[TBL] [Abstract][Full Text] [Related]
16. Post hysterectomy mesonephric carcinoma: A case report and literature review.
Kumar S; Sucheta ; Saklani B; Archana ; Kapil R; Sen R
J Cancer Res Ther; 2022; 18(1):277-279. PubMed ID: 35381800
[TBL] [Abstract][Full Text] [Related]
17. Lobular endocervical glandular hyperplasia is a metaplastic process with a pyloric gland phenotype.
Mikami Y; Hata S; Melamed J; Fujiwara K; Manabe T
Histopathology; 2001 Oct; 39(4):364-72. PubMed ID: 11683936
[TBL] [Abstract][Full Text] [Related]
18. Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation.
Ordi J; Nogales FF; Palacin A; Márquez M; Pahisa J; Vanrell JA; Cardesa A
Am J Surg Pathol; 2001 Dec; 25(12):1540-5. PubMed ID: 11717545
[TBL] [Abstract][Full Text] [Related]
19. Squamous cell carcinoma in situ involving mesonephric remnants of the uterine cervix.
Zámecník M
Cesk Patol; 2004 Jul; 40(3):109-11. PubMed ID: 15493419
[TBL] [Abstract][Full Text] [Related]
20. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β.
Kenny SL; McBride HA; Jamison J; McCluggage WG
Am J Surg Pathol; 2012 Jun; 36(6):799-807. PubMed ID: 22456609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
